BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2021 2:11:51 AM | Browse: 826 | Download: 1723
 |
Received |
|
2021-03-31 13:45 |
|
Peer-Review Started |
|
2021-03-31 14:09 |
|
First Decision by Editorial Office Director |
|
2021-06-23 06:35 |
|
Return for Revision |
|
2021-06-23 06:35 |
|
Revised |
|
2021-06-28 03:38 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-08-03 03:29 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-08-03 08:21 |
|
Articles in Press |
|
2021-08-03 08:21 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-08-23 10:33 |
|
Publish the Manuscript Online |
|
2021-08-25 02:11 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Immune checkpoint inhibitor-related hepatotoxicity: A review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Devika Remash, David S Prince, Catriona McKenzie, Simone I Strasser, Steven Kao and Ken Liu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ken Liu, BSc, FRACP, MBBS, Consultant Physician-Scientist, Senior Lecturer, Staff Physician, AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Missenden Road, Camperdown, Sydney 2050, NSW, Australia. ken.liu@health.nsw.gov.au |
| Key Words |
Immunotherapy; Immune checkpoint inhibitors; Hepatitis; Adverse drug event; Drug-induced liver injury; Immunosuppression |
| Core Tip |
Immune checkpoint inhibitor (ICI)-related hepatotoxicity (ICH) is an increasingly encountered clinical problem for gastroenterologists. Although the diagnosis should be suspected in patients receiving ICI with liver function test derangements, a thorough history, examination and targeted liver investigations including cross-sectional imaging should be performed to exclude differential diagnoses. Once ICH is confirmed, its severity should be graded which then guides management. Management of ICH follows a stepwise approach beginning with cessation of ICI, followed by corticosteroids and other immunosuppressants with close monitoring after each step. The decision to recommence ICI after recovery is made on a case-by-case basis. |
| Publish Date |
2021-08-25 02:11 |
| Citation |
Remash D, Prince DS, McKenzie C, Strasser SI, Kao S, Liu K. Immune checkpoint inhibitor-related hepatotoxicity: A review. World J Gastroenterol 2021; 27(32): 5376-5391 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i32/5376.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i32.5376 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
